相关实验视频

Updated: Sep 20, 2025

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

ITGA5通过TAK-1/NF-kB激活驱动糖尿病视网膜病变中的血管生成

Feifei Kan¹, Di Wang¹, Sijia Li¹

¹Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, Heilongjiang, China.

|May 23, 2025

概括

综合素子单元阿尔法5 (ITGA5) 通过激活TAK-1/NF-kB通路,促进糖尿病视网膜病变中的血管生成. 沉默ITGA5减少了新血管化和相关标记物,提供了一个潜在的治疗点.

科学领域:

眼科医生眼科眼科
血管生物学血管生物学
分子医学是分子医学.

背景情况:

糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因.
整合素子单元阿尔法5 (ITGA5) 在DR病变发生中的作用尚不清楚.
了解ITGA5的功能可能会为DR揭示新的治疗点.

研究的目的:

研究ITGA5在糖尿病视网膜病变中的作用.
阐明ITGA5影响DR中的血管生成的分子机制.
在DR模型中评估ITGA5干扰的治疗潜力.

主要方法:

在老鼠中使用链毒素诱导糖尿病.
ITGA5通过内腺相关病毒输送受到干扰.
在体外研究中,在高葡萄糖条件下使用大鼠视网膜微血管内皮细胞 (RRMECs).
用氧诱导视网膜病变模型来评估新血管化.

主要成果:

在糖尿病老鼠视网膜中,ITGA5被上调.
降低ITGA5 knockdown减少了新血管化,非细胞毛细血管和细胞周损失.
在ITGA5干扰下降了VEGFA,VCAM-1和ICAM-1的表达.
通过ITGA5倒置,抑制了TAK-1/NF-kB通路的激活.

结论:

ITGA5在促进糖尿病视网膜病变中的血管生成方面发挥着重要作用.
通过激活TAK-1/NF-kB通路,ITGA5有助于DR病理.
向ITGA5可能是治疗糖尿病视网膜病变的新治疗策略.

关键词:

血管新生的产生.糖尿病视网膜病变 - 糖尿病视网膜病变集成素亚单元α5 (ITGA5) 是一个集成素亚单元.通过TAK-1/NF-kB通路.

更多相关视频

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

Retinal Pathophysiological Evaluation in a Rat Model

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...